<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01184625</url>
  </required_header>
  <id_info>
    <org_study_id>Exercise</org_study_id>
    <nct_id>NCT01184625</nct_id>
  </id_info>
  <brief_title>Physical Exercise as a Targeted Therapy in Patients With Chronic Rheumatic Muscle Inflammation</brief_title>
  <official_title>Physical Exercise as a Targeted Therapy in Patients With Chronic Rheumatic Muscle Inflammation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska Institutet</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Uppsala University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sahlgrenska University Hospital, Sweden</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Karolinska Institutet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objectives of this study are to test if hypoxia in muscle tissue is an important factor
      contributing to clinical symptoms in chronic rheumatic muscle inflammation and to evaluate if
      a 12 week endurance exercise program will improve muscle tissue hypoxia and disability in
      patients with chronic rheumatic muscle inflammation.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2008</start_date>
  <completion_date type="Anticipated">August 2012</completion_date>
  <primary_completion_date type="Anticipated">January 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hypoxia related metabolites.</measure>
    <time_frame>At baseline before intervention.</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Hypoxia related metabolites.</measure>
    <time_frame>After 12 weeks of endurance exercise intervention/ non intervention.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Muscle impairment.</measure>
    <time_frame>At baseline before intervention.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscle impairment.</measure>
    <time_frame>After 12 weeks of endurance exercise intervention/ non intervention.</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Myositis</condition>
  <arm_group>
    <arm_group_label>Exercise</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>No intervention</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>12 weeks of stable physical exercise level.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Physical Exercise</intervention_name>
    <description>12 weeks of physical exercise.</description>
    <arm_group_label>Exercise</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with chronic, stable polymyositis or dermatomyositis with diagnosis of
             definite or probable polymyositis or dermatomyositis (Bohan and Peter 1975)

          -  Age 18-80 years

          -  Duration since diagnosis &gt; 6 months

          -  Exercising &lt; once a week,

          -  Stable disease activity and medication for at least one month.

        Ten healthy controls matched for age, gender and physical exercise level will be included.

        Exclusion Criteria:

          -  Severe pulmonary fibrosis

          -  Heart or lung conditions that contraindicate vigorous exercise

          -  Severe osteoporosis

          -  Not being able to perform the exercise program.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ingrid E Lundberg, MD, PhD, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rheumatology Unit, Department of Medicine, in Solna, Karolinska Institutet</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ingrid E Lundberg, MD, PhD, Prof</last_name>
    <phone>+46 8 517700</phone>
    <phone_ext>6087</phone_ext>
    <email>ingrid.lundberg@ki.se</email>
  </overall_contact>
  <location>
    <facility>
      <name>Rheumatology unit, Karolinska University Hospital</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ingrid E Lundberg, MD, PhD, Prof</last_name>
      <phone>+46 8 517700</phone>
      <phone_ext>6087</phone_ext>
      <email>ingrid.lundberg@ki.se</email>
    </contact>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>June 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 17, 2010</study_first_submitted>
  <study_first_submitted_qc>August 18, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 19, 2010</study_first_posted>
  <last_update_submitted>June 24, 2011</last_update_submitted>
  <last_update_submitted_qc>June 24, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 27, 2011</last_update_posted>
  <responsible_party>
    <name_title>professor Ingrid Lundberg</name_title>
    <organization>Karolinska Institutet</organization>
  </responsible_party>
  <keyword>Myositis</keyword>
  <keyword>Physical exercise</keyword>
  <keyword>Disability</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Myositis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

